文献速递心力衰竭与心肌病

肥胖诱导的JunD激活促进心肌脂质蓄积与代谢性心肌病

Obesity-induced activation of JunD promotes myocardial lipid accumulation and metabolic cardiomyopathy.
PubMed 文献 · Eur Heart J · 2019-01-01

该研究在饮食诱导肥胖小鼠及肥胖患者心肌标本中探究JunD在代谢性心肌病中的作用。JunD转录活性升高与心肌甘油三酯蓄积及左室功能障碍相关,敲除JunD可保护小鼠免于代谢性心肌病。机制上JunD直接结合PPARγ启动子促进脂质合成摄取水解储存基因转录,且受miR-494-3p靶向调控,构成miR-494-3p/JunD新分子轴。

要点

  • JunD在肥胖心脏中转录活性升高,与心肌TG蓄积和左室功能障碍相关。
  • 敲除JunD可保护肥胖小鼠免于代谢性心肌病。
  • miR-494-3p下调导致JunD/PPARγ信号激活,过表达miR-494-3p可减轻脂毒性损伤。

核心结论

  • miR-494-3p/JunD是参与肥胖相关代谢性心肌病的新分子轴,为预防或治疗肥胖患者左室功能障碍提供途径。

研究设计与样本

  • 研究采用饮食诱导肥胖小鼠模型、离体新生大鼠心室肌细胞棕榈酸暴露实验,并分析肥胖与非肥胖患者心肌标本。

主要发现

  • 饮食诱导肥胖小鼠心脏中JunD转录活性升高,伴随心肌甘油三酯蓄积和左室功能障碍。
  • 缺乏JunD的肥胖小鼠免于代谢性心肌病。
  • 在饮食诱导肥胖心脏中,JunD直接结合PPARγ启动子,促进Fas、Cd36、Lpl、Plin5等参与TG合成、摄取、水解和储存的基因转录。
  • 瘦小鼠心脏特异性过表达JunD导致PPARγ激活、心脏脂肪变性和功能障碍,模拟代谢性心肌病表型。
  • 在饮食诱导肥胖心脏及棕榈酸暴露的新生大鼠心室肌细胞中,Ago2免疫沉淀和荧光素酶实验显示JunD是miR-494-3p的直接靶标;肥胖小鼠心脏中miR-494-3p下调,其过表达通过抑制JunD/PPARγ信号防止脂毒性损伤。

临床怎么用

  • miR-494-3p/JunD轴可能作为肥胖相关代谢性心肌病的潜在干预靶点,用于预防或治疗肥胖患者左室功能障碍。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Metabolic cardiomyopathy (MC)-characterized by intra-myocardial triglyceride (TG) accumulation and lipotoxic damage-is an emerging cause of heart failure in obese patients. Yet, its mechanisms remain poorly understood. The Activator Protein 1 (AP-1) member JunD was recently identified as a key modulator of hepatic lipid metabolism in obese mice. The present study investigates the role of JunD in obesity-induced MC. METHODS AND RESULTS: JunD transcriptional activity was increased in hearts from diet-induced obese (DIO) mice and was associated with myocardial TG accumulation and left ventricular (LV) dysfunction. Obese mice lacking JunD were protected against MC. In DIO hearts, JunD directly binds PPARγ promoter thus enabling transcription of genes involved in TG synthesis, uptake, hydrolysis, and storage (i.e. Fas, Cd36, Lpl, Plin5). Cardiac-specific overexpression of JunD in lean mice led to PPARγ activation, cardiac steatosis, and dysfunction, thereby mimicking the MC phenotype. In DIO hearts as well as in neonatal rat ventricular myocytes exposed to palmitic acid, Ago2 immunoprecipitation, and luciferase assays revealed JunD as a direct target of miR-494-3p. Indeed, miR-494-3p was down-regulated in hearts from obese mice, while its overexpression prevented lipotoxic damage by suppressing JunD/PPARγ signalling. JunD and miR-494-3p were also dysregulated in myocardial specimens from obese patients as compared with non-obese controls, and correlated with myocardial TG content, expression of PPARγ-dependent genes, and echocardiographic indices of LV dysfunction. CONCLUSION: miR-494-3p/JunD is a novel molecular axis involved in obesity-related MC. These results pave the way for approaches to prevent or treat LV dysfunction in obese patients.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Costantino S, Akhmedov A, Melina G, et al. Obesity-induced activation of JunD promotes myocardial lipid accumulation and metabolic cardiomyopathy. Eur Heart J. 2019. PMID: 30629164. doi:10.1093/eurheartj/ehy903

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。